T1	Disorder 32 40	diabetes
N1 	Reference T1 UMLS:C0011860	diabetes
N2 	Reference T1 UMLS:C0011849	diabetes
T2	Disorder 57 69	hypertension
N3 	Reference T2 UMLS:C0020538	hypertension
T3	Pharmacological_substance 75 85	indapamide
N1000 	Reference T3 MeSH:D007190	indapamide
T4	Pharmacological_substance 146 156	indapamide
N1001 	Reference T4 MeSH:D007190	indapamide
T5	Disorder 194 216	essential hypertension
N4 	Reference T5 UMLS:C1541808	essential hypertension
N5 	Reference T5 UMLS:C0085580	essential hypertension
T6	Disorder 285 293	diabetes
N6 	Reference T6 UMLS:C0011860	diabetes
N7 	Reference T6 UMLS:C0011849	diabetes
T7	Pharmacological_substance 305 315	indapamide
N1002 	Reference T7 MeSH:D007190	indapamide
T8	Disorder 340 362	essential hypertension
N8 	Reference T8 UMLS:C1541808	essential hypertension
N9 	Reference T8 UMLS:C0085580	essential hypertension
T9	Pharmacological_substance 441 451	indapamide
N1003 	Reference T9 MeSH:D007190	indapamide
T11	Pharmacological_substance 555 565	indapamide
N1004 	Reference T11 MeSH:D007190	indapamide
T13	Pharmacological_substance 583 593	fosinopril
N1005 	Reference T13 MeSH:D017328	fosinopril
T15	Pharmacological_substance 663 673	indapamide
N1006 	Reference T15 MeSH:D007190	indapamide
T17	Disorder 768 776	diabetes
N10 	Reference T17 UMLS:C0011860	diabetes
N11 	Reference T17 UMLS:C0011849	diabetes
T19	Pharmacological_substance 835 845	indapamide
N1007 	Reference T19 MeSH:D007190	indapamide
T20	Disorder 892 900	diabetes
N12 	Reference T20 UMLS:C0011860	diabetes
N13 	Reference T20 UMLS:C0011849	diabetes
T21	Pharmacological_substance 939 949	indapamide
N1008 	Reference T21 MeSH:D007190	indapamide
T22	Disorder 961 969	diabetes
N14 	Reference T22 UMLS:C0011860	diabetes
N15 	Reference T22 UMLS:C0011849	diabetes
T23	Disorder 973 995	essential hypertension
N16 	Reference T23 UMLS:C1541808	essential hypertension
N17 	Reference T23 UMLS:C0085580	essential hypertension
T24	Pharmacological_substance 1021 1031	indapamide
N1009 	Reference T24 MeSH:D007190	indapamide
T14	Subject 217 225	patients
T16	Subject 373 393	1 male and 3 females
T25	Subject 996 1004	patients
T26	Disorder 1033 1060	glucose tolerance impairing
N18 	Reference T26 UMLS:C0271650	glucose tolerance impairing
T31	Speculation_cue 10 18	Possible
T33	Disorder 157 190	impairing carbohydrate metabolism
T36	Subject 609 623	three patients
T37	Subject 690 701	one patient
T39	Subject 721 733	all patients
T10	Speculation_cue 950 953	may
T27	Subject 865 877	all patients
T50	Speculation_cue 127 132	study
T35	Combination 540 551	combination
